UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in PCRX — Pacira BioSciences, Inc.
CIK 861177
NEW YORK, NY
Position in PCRX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,662,241
-$11,740 QoQ
Shares Held
65,520
-11.5% QoQ
Ownership
0.164%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#73
of 254 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in PCRX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $852,377,607 across 33 Drug Manufacturers - Specialty & Generic names. PCRX ranks #20 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,924,988 | $282,049,632 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,832,465 | $129,843,910 | |
| 3 | UTHR |
UNITED THERAPEUTICS Corp
|
218,164 | $118,207,795 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
504,233 | $84,983,427 | |
| 5 | VTRS |
Viatris Inc
|
4,293,757 | $68,184,856 | |
| 6 | LNTH |
Lantheus Holdings, Inc.
|
482,743 | $53,555,505 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
1,510,327 | $37,169,144 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
425,977 | $14,768,619 |
All Filings in PCRX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,662,241 | 65,520 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $1,673,981 | 74,070 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $1,901,273 | 73,465 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $1,966,173 | 76,297 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,397,050 | 142,136 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $2,346,584 | 94,430 | Shares | Defined | 2025-05-19 | |
| 2024-12-31 | $1,975,467 | 104,855 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $1,250,263 | 83,074 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $3,030,168 | 105,913 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,464,971 | 50,136 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $1,691,586 | 50,136 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,538,171 | 50,136 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $1,915,743 | 47,810 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,951,124 | 47,810 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $1,667,641 | 43,192 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $2,297,380 | 43,192 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $3,143,942 | 53,927 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $4,075,637 | 53,402 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $3,062,108 | 50,891 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $2,849,896 | 50,891 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,088,063 | 50,891 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $3,309,017 | 47,211 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $2,850,297 | 47,632 | Shares | Defined | 2021-03-01 | |
| 2020-09-30 | $2,657,723 | 44,207 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $2,184,795 | 41,639 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,598,608 | 47,677 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||